AVXL

JonesTrading analyst Soumit Roy maintained a Buy rating on Anavex Life Sciences (AVXL - Research Report) today and set a price target of $80.00. The company's shares opened today at $12.03.Roy covers the Healthcare sector, focusing on stocks such as Aeglea Biotherapeutics, Mirati Therapeutics, and Curis. According to TipRanks, Roy has an average return of 7.2% and a 33.75% success rate on recommended stocks. Anavex Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $49.25, implying a 309.39% upside from current levels. In a report released on December 2, Berenberg Bank also maintained a Buy rating on the stock with a $40.00 price target.
https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-its-buy-rating-for-anavex-life-sciences-avxl?utm_source=advfn.com&utm_medium=referral